ZNF605 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.55111512312578E-16 |
Normal-vs-Stage2 |
2.05459999998991E-05 |
Normal-vs-Stage3 |
1.38129507831763E-11 |
Normal-vs-Stage4 |
6.39090003140552E-10 |
Stage1-vs-Stage2 |
7.461400E-01 |
Stage1-vs-Stage3 |
9.452200E-01 |
Stage1-vs-Stage4 |
2.582800E-01 |
Stage2-vs-Stage3 |
8.038200E-01 |
Stage2-vs-Stage4 |
2.931200E-01 |
Stage3-vs-Stage4 |
2.617200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62436730732907E-12 |
Normal-vs-AfricanAmerican |
1.95489999743614E-08 |
Normal-vs-Asian |
2.443700E-03 |
Caucasian-vs-AfricanAmerican |
3.624400E-01 |
Caucasian-vs-Asian |
5.513900E-02 |
AfricanAmerican-vs-Asian |
1.318570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.9960036108132E-15 |
Normal-vs-Female |
1.62436730732907E-12 |
Male-vs-Female |
3.035700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.039970E-03 |
Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(61-80Yrs) |
2.53508325442908E-12 |
Normal-vs-Age(81-100Yrs) |
1.091700E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.177600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.699200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.165800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.750310E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.490440E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.770800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.05889999999443E-05 |
Normal-vs-Grade 2 |
1.62503344114384E-12 |
Normal-vs-Grade 3 |
1.63447033685316E-12 |
Normal-vs-Grade 4 |
1.28309999958276E-07 |
Grade 1-vs-Grade 2 |
9.084400E-02 |
Grade 1-vs-Grade 3 |
3.828200E-02 |
Grade 1-vs-Grade 4 |
1.248210E-01 |
Grade 2-vs-Grade 3 |
5.553600E-01 |
Grade 2-vs-Grade 4 |
9.104600E-01 |
Grade 3-vs-Grade 4 |
7.830000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.11022302462516E-16 |
Normal-vs-ccB subtype |
4.36419789195952E-11 |
ccA subtype-vs-ccB subtype |
5.193800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.8746783559418E-14 |
Normal-vs-N1 |
1.740210E-03 |
N0-vs-N1 |
1.065380E-01 |
|
|